A share price of CME Group Inc [CME] is currently trading at $225.28, up 2.10%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CME shares have gain 3.26% over the last week, with a monthly amount glided 4.42%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on September 27, 2024, when RBC Capital Mkts initiated its Sector Perform rating and assigned the stock a price target of $235. Previously, TD Cowen started tracking the stock with Hold rating on September 26, 2024, and set its price target to $221. On September 03, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $177 on the stock. JP Morgan downgraded its rating to a Underweight and decreased its price target to $187 on June 21, 2024. Barclays downgraded its rating to a Equal Weight and reduced its price target to $222 on January 08, 2024. Goldman downgraded its rating to Sell for this stock on January 03, 2024, but kept the price target unchanged to $195. In a note dated September 06, 2023, BofA Securities upgraded an Neutral rating on this stock and boosted its target price from $167 to $204.
CME Group Inc experienced fluctuations in its stock price throughout the past year between $190.70 and $222.63. Currently, Wall Street analysts expect the stock to reach $215.12 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $225.28 at the most recent close of the market. An investor can expect a potential drop of -4.51% based on the average CME price forecast.
Analyzing the CME fundamentals
Trailing Twelve Months sales for CME Group Inc [NASDAQ:CME] were 5.80B which represents 12.67% growth. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at 0.63%, Pretax Profit Margin comes in at 0.73%, and Net Profit Margin reading is 0.57%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.12 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 220.47 points at the first support level, and at 215.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 227.70, and for the 2nd resistance point, it is at 230.13.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 13.99, the price to book ratio is 2.93 and price to earnings (TTM) ratio is 24.85.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Sep 25 ’24 when 280.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Sep 25 ’24 to buy 12.0 shares. Meanwhile, Sr MD Chief Financial Officer Fitzpatrick Lynne sold 754.0 shares on Sep 15 ’24.
